Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$122K Hold
2,323
0.02% 97
2026
Q1
$128K Hold
2,323
0.02% 88
2025
Q4
$114K Hold
2,323
0.02% 92
2025
Q3
$100K Sell
2,323
-177
-7% -$6.91K 0.02% 97
2025
Q2
$96K Hold
2,500
0.02% 96
2025
Q1
$96.8K Hold
2,500
0.02% 95
2024
Q4
$84.5K Hold
2,500
0.02% 108
2024
Q3
$102K Hold
2,500
0.02% 36
2024
Q2
$96.3K Hold
2,500
0.02% 38
2024
Q1
$107K Buy
+2,500
New +$103K 0.03% 32
2022
Q3
Sell
-5,941
Closed -$323K 22
2022
Q2
$323K Hold
5,941
0.11% 18
2022
Q1
$323K Hold
5,941
0.1% 18
2021
Q4
$327K Hold
5,941
0.09% 19
2021
Q3
$284K Hold
5,941
0.09% 20
2021
Q2
$296K Hold
5,941
0.09% 21
2021
Q1
$265K Sell
5,941
-17,823
-75% -$809K 0.08% 22
2020
Q4
$1.09M Buy
+23,764
New +$1.09M 0.4% 13

Other funds holding GSK

ESL Trust Services's GSK Position: Q2 2026 in Review

ESL Trust Services held its GSK (GSK) position steady in Q2 2026 at 2,323 shares worth $122K. The position accounts for 0.02% of the portfolio, ranked #97.

ESL Trust Services first reported a position in GSK in Q4 2020 and has held it in 17 quarters since. The position peaked at $1.09M in Q4 2020. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • ESL Trust Services held 2,323 shares of GSK worth $122K as of Q2 2026.
  • ESL Trust Services left its GSK share count unchanged in Q2 2026.
  • GSK made up 0.02% of ESL Trust Services's portfolio in Q2 2026, its #97 holding.
  • ESL Trust Services first reported a position in GSK in Q4 2020 and has held it in 17 quarters since.
  • ESL Trust Services's GSK position peaked at $1.09M in Q4 2020.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on ESL Trust Services's 13F filing for Q2 2026, filed 13 Aug 2026.